GlassScriptPhysician profile
Terry A Holster
NPI 1326087040
$6,468.50
in general payments reported to CMS, 2019-2025
44 companies · $866 in 2025
The $866 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $798 · 2021: $1,025 · 2022: $1,413 · 2023: $1,005 · 2024: $1,084 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,942 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,941.67 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,133.10 | 2019-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $1,050.60 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $903.06 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Amarin Pharma, INC. | $427.57 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $425.49 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Antares Pharma, INC. | $296.31 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $237.61 | 2019-2025 | |
| Glaxosmithkline, LLC. | $186.79 | 2020-2024 | Arexvy, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $168.87 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.28 | 2021-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $113.15 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Exact Sciences Corporation | $108.74 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $99.33 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $87.18 | 2019-2021 | |
| Esperion Therapeutics, INC. | $84.76 | 2021-2025 | Nexletol |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Holster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.